Jentashapir Journal of Health Research

Published by: Neoscriber Demo Publisher

Prevalence of Diabetes Type 1 in Patients Suffered From Multiple Sclerosis

Dian Dayer 1 , * , Forough Abdollahzadeh 1 , Zeinab Nadery 1 and Nastaran Madjdi Nasab 2
Authors Information
1 Department of Medical Laboratory Sciences, Para-Medical Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jentashapir Journal of Health Research: April 2016, 7 (2); e35828
  • Published Online: April 16, 2016
  • Article Type: Research Article
  • Received: January 9, 2016
  • Accepted: March 10, 2016
  • DOI: 10.17795/jjhr-35828

To Cite: Dayer D, Abdollahzadeh F, Nadery Z, Madjdi Nasab N. Prevalence of Diabetes Type 1 in Patients Suffered From Multiple Sclerosis, Jundishapur J Helath Res. 2016 ;7(2):e35828. doi: 10.17795/jjhr-35828.

Abstract
Copyright: Copyright © 2016, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Handel AE, Handunnetthi L, Ebers GC, Ramagopalan SV. Type 1 diabetes mellitus and multiple sclerosis: common etiological features. Nat Rev Endocrinol. 2009; 5(12): 655-64[DOI][PubMed]
  • 2. Nakahara J, Maeda M, Aiso S, Suzuki N. Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy. Clin Rev Allergy Immunol. 2012; 42(1): 26-34[DOI][PubMed]
  • 3. Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet. 2002; 359(9316): 1461-5[DOI][PubMed]
  • 4. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet. 1998; 7(8): 1235-7[PubMed]
  • 5. Lampis R, Morelli L, De Virgiliis S, Congia M, Cucca F. The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens. 2000; 56(6): 515-21[PubMed]
  • 6. Dorman JS, Steenkiste AR, Burke JP, Songini M. Type 1 diabetes and multiple sclerosis: together at last. Diabetes Care. 2003; 26(11): 3192-3[PubMed]
  • 7. Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009; 5(1)[DOI][PubMed]
  • 8. Baranzini SE. Revealing the genetic basis of multiple sclerosis: are we there yet? Curr Opin Genet Dev. 2011; 21(3): 317-24[DOI][PubMed]
  • 9. Etemadifar M, Abtahi SH. Multiple sclerosis in Isfahan, Iran: Past, Present and Future. Int J Prev Med. 2012; 3(5): 301-2[PubMed]
  • 10. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S. Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg. 2013; 115(3): 304-8[DOI][PubMed]
  • 11. Nielsen NM, Westergaard T, Frisch M, Rostgaard K, Wohlfahrt J, Koch-Henriksen N, et al. Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. Arch Neurol. 2006; 63(7): 1001-4[DOI][PubMed]
  • 12. Bechtold S, Blaschek A, Raile K, Dost A, Freiberg C, Askenas M, et al. Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: analysis from DPV database. Diabetes Care. 2014; 37(1): 96-101[DOI][PubMed]
  • 13. Winer S, Astsaturov I, Cheung R, Gunaratnam L, Kubiak V, Cortez MA, et al. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J Immunol. 2001; 166(4): 2831-41[PubMed]
  • 14. Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Study Research G, Jacobson AM, Musen G, Ryan CM, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007; 356(18): 1842-52[DOI][PubMed]
  • 15. Jeffcoate W. Drive to eliminate the burden of type 1 diabetes. Lancet. 2006; 367(9513): 795-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader